Volume 4, Emitir 1 (2014)
Revisão: Resultados da Trilha Clínica
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Perspectiva da Trilha Clínica
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Revisão: Resultados da Trilha Clínica
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Revisão: Resultados da Trilha Clínica
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Revisão: Resultados da Trilha Clínica
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Revisão: Resultados da Trilha Clínica
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Perspectiva da Trilha Clínica
Inclusion of older people in interventional clinical trials
Prabhath Fernando, Amit Arora, Peter Crome
